Why the study?
Does chronic vasodilator therapy improve heart size and functional status in a patient with cardiogenic shock and intractable left ventricular failure?
Does chronic vasodilator therapy improve heart size and functional status in a patient with cardiogenic shock and intractable left ventricular failure?
Chronic reduction of impedance to left ventricular ejection via vasodilator therapy may be a useful approach for severe left ventricular failure.
Answers are grounded in this paper and cite their sources.
May support vasodilator trial in refractory LV failure; hypothesis-generating case report that leaves efficacy open in cardiogenic shock.
A patient with cardiogenic shock and intractable left ventricular failure due to coronary artery disease was treated with a 21-day infusion of sodium nitroprusside followed by chronic administration of nitrates by mouth and topically. Heart size has returned nearly to normal, and functional status has markedly improved. Hemodynamic and clinical deterioration occurred initially whenever the nitroprusside infusion was stopped and more recently when the chronic vasodilator therapy was discontinued. These observations suggest that chronic reduction of impedance to left ventricular ejection may be a useful approach to the treatment of severe left ventricular failure.
No takes yet. Share an insight, caveat, or question.
Jay N. Cohn (1974) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: